SCHEMBL796030

SCHEMBL796030

FCCOc1ccc2c(c1)sc1nc(-c3ccc(I)[nH]3)cn12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.61
MAPT P10636 5/20 0.44
TP53 P04637 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
FLT3 P36888 9/20 0.38
KDR P35968 2/20 0.37
BMPR1B O00238 1/20 0.37
MUSK O15146 1/20 0.37
EPHB6 O15197 1/20 0.37
MAP3K7 O43318 1/20 0.37
RIPK2 O43353 1/20 0.37
PAK3 O75914 1/20 0.37
STK10 O94804 1/20 0.37
MAP4K4 O95819 1/20 0.37
ABL1 P00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL796947 0.82 APP (0.76) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL796023 0.82 APP (0.64) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL1853165 0.79 APP (0.77) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL796250 0.78 APP (0.69) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL796951 0.78 APP (0.70) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL1852674 0.77 APP (0.63) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL1854899 0.76 APP (0.62) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL13394587 0.76 APP (0.67) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL13290984 0.76 APP (0.75) APPMAPTTP53SMN1; SMN2LMNA
SCHEMBL796995 0.76 APP (1.00) APPMAPTTP53SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
WO-2010092111-A2 COMPOUNDS FOR NON-INVASIVE MEASUREMENT OF AGGREGATES OF AMYLOID PEPTIDES Technische Universität München (DE) 2010-08-19 WO disclosed
EP-2218464-A1 Compounds for non-invasive measurement of aggregates of amyloid peptides Technische Universität München (DE) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT APP 2/4885MAPT 10/4885TP53 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.